Gilliam Joseph E 4
Accession 0001705850-26-000002
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 8:42 PM ET
Size
12.2 KB
Accession
0001705850-26-000002
Research Summary
AI-generated summary of this filing
GLAUKOS (GKOS) President Joseph Gilliam Sells Shares
What Happened Joseph E. Gilliam, President and COO of GLAUKOS Corp (GKOS), exercised options and sold shares on January 21, 2026. He exercised 4,502 option shares at an exercise price of $55.18 (cost $248,420) and immediately sold those 4,502 shares in the market at a weighted-average price of $124.65, producing proceeds of $561,174. The filing also reports the disposition/conversion of two additional derivative tranches (2,602 and 1,900 shares) reported with $0 per-share cash proceeds; these represent portions of previously granted option awards subject to multi-year performance vesting.
Key Details
- Transaction date: January 21, 2026.
- Option exercise: 4,502 shares exercised at $55.18/share (total exercise cost $248,420).
- Sale: 4,502 shares sold at a weighted-average price of $124.65/share (total proceeds $561,174); trade prices ranged $124.47–$124.75 per footnote.
- Additional derivative items: 2,602 and 1,900 shares reported as disposed at $0 (relate to performance-based option tranches granted March 24, 2022).
- Plan disclosure: Both the sales and the option exercises were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2025.
- Unvested awards: Filing notes 62,605 restricted stock units that have not yet vested or been delivered to the reporting person.
- Filing timeliness: Reported on Jan 23, 2026 for a Jan 21 transaction — appears timely (Form 4 is due within two business days).
Context This was a same-day exercise-and-sell transaction under a pre-established 10b5-1 plan (exercise executed and shares sold that day), which is commonly used to automate insider selling and avoid questions about timing. The additional zero-price derivative entries reflect conversion/settlement of previously granted performance-based option tranches rather than a cash sale. As with all insider filings, these are factual disclosures and do not by themselves indicate the reporting person's future view of the company.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-01-21$55.18/sh+4,502$248,420→ 96,868 total - Sale
Common Stock
[F2][F3][F1]2026-01-21$124.65/sh−4,502$561,174→ 92,366 total - Exercise/Conversion
Stock Option (Right to Buy)
[F4][F5]2026-01-21−2,602→ 62,411 totalExercise: $55.18Exp: 2032-03-24→ Common Stock (2,602 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F4][F6]2026-01-21−1,900→ 33,813 totalExercise: $55.18Exp: 2032-03-24→ Common Stock (1,900 underlying)
Footnotes (6)
- [F1]Includes 62,605 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025.
- [F3]This transaction was executed in multiple trades at prices ranging from $124.47 to $124.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]The option exercises reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025.
- [F5]Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.
- [F6]Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals.
Signature
Documents
Issuer
GLAUKOS Corp
CIK 0001192448
Related Parties
1- filerCIK 0001705850
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 8:42 PM ET
- Size
- 12.2 KB